Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail. The Company assumes no responsibility for this translation or for direct, indirect or any other forms of damages arising from the translation.

Stock Exchange Code 4530 May 2, 2024 (Start date of measures for electronic provision: April 26, 2024)

To Shareholders with Voting Rights:

Kazuhide Nakatomi

President & CEO

Hisamitsu Pharmaceutical Co., Inc.

408 Tashiro Daikan-machi, Tosu, Saga

NOTICE OF CONVOCATION OF

THE 122ND ANNUAL GENERAL MEETING OF SHAREHOLDERS

We would like to express our appreciation for your continued support and patronage.

We would also like to express our heartfelt sympathy to all those affected by the 2024 Noto Peninsula Earthquake and sincerely hope for the earliest possible recovery.

This is to notify you that the 122nd Annual General Meeting of Shareholders of Hisamitsu Pharmaceutical Co., Inc. (the "Company") will be held for the purposes as described below.

In convening the General Meeting of Shareholders, the Company has taken measures for electronic provision and has posted the matters subject to electronic provision on the Company's website. Please access the Company's website below to see the information.

The Company's website https://global.hisamitsu/ir/shareholders.html

In addition to the Company's website, the matters subject to electronic provision are also posted on the website of the Tokyo Stock Exchange (TSE). When you access the TSE website, search for the Company by entering "Hisamitsu Pharmaceutical" in the "Issue name (company name)" bar or the Company's stock exchange code "4530" in the "Code" bar, continue selecting "Basic information" and "Documents for public inspection/PR information" and choose "Notice of General Shareholders Meeting/Informational Materials for a General Shareholders Meeting" under "Filed information available for public inspection" to see the matters.

TSE website (Listed Company Search) https://www2.jpx.co.jp/tseHpFront/JJK020010Action.do?Show=Show

In lieu of attending the meeting, you may exercise your voting rights via electromagnetic means, including the Internet, or in writing. In this case, please review the attached Reference Documents for the General Meeting of Shareholders and exercise your voting rights.

1.

Date and Time:

Thursday, May 23, 2024 at 10:00 a.m. Japan time

2.

Place:

Head office of the Company located at

408 Tashiro Daikan-machi, Tosu, Saga, Japan

- 1 -

3. Meeting Agenda:

Matters to be reported: 1. The Business Report, Consolidated Financial Statements and Non-

consolidated Financial Statements for the Company's 122nd Fiscal Year (March 1, 2023 - February 29, 2024)

2. Results of audits by the Independent Auditor and the Board of Corporate Auditors of the Consolidated Financial Statements for the Company's 122nd Fiscal Year

Proposals to be resolved:

Proposal 1: Appropriation of Surplus

Proposal 2: Election of 9 Directors

Proposal 3: Election of 3 Corporate Auditors

(The details of the meeting agenda and other matters are stated in the following pages.)

4. Matters decided for convocation

- Items not stated in a document delivered to shareholders

The document delivered to shareholders also serves as a document that states the matters subject to electronic provision, which is delivered to shareholders who have requested a paper copy of it. In accordance with applicable laws and regulations and Article 14 of the Articles of Incorporation of the Company, the following items are not included in it. Please note that the Corporate Auditors and the Independent Auditor have audited documents, including the following items.

  1. Matters Regarding Share Acquisition Rights, etc. of the Company, Status of Independent Auditor, and Structure and Policy of the Company in the Business Report
  2. Consolidated Statements of Changes in Shareholders' Equity and Notes to Consolidated Financial Statements in the Consolidated Financial Statements
  3. Non-consolidatedStatement of Changes in Shareholders' Equity and Notes to Non-consolidated Financial Statements in the Non-consolidated Financial Statements

- 2 -

Reference Documents for the General Meeting of Shareholders

Proposal 1: Appropriation of Surplus

The Company regards the appropriate return of profits to shareholders as one of the most important management issues.

With respect to dividends of surplus at the end of the fiscal year under review, upon comprehensively examining factors such as the performance for the fiscal year, dividend payout ratios and various management measures for the future in addition to taking into account the stable distribution of dividends to shareholders, the Company proposes to pay a dividend of ¥42.5 per share as follows. Accordingly, the annual dividend including an interim dividend of ¥42.5 will be ¥85 per share, an increase from the annual dividend of ¥84.5 per share for the previous fiscal year.

In addition, the Company recognizes the need to strengthen its financial structure to provide for the stable return of profits to its shareholders and future business development, and therefore intends to allocate ¥3.0 billion to general reserve as follows.

1. Matters concerning dividends of surplus

  1. Allotment of dividend properties to shareholders and the total amount thereof

¥42.5 per share of the Company's common stock

Total payment of dividends: ¥3,220,341,578

  1. Effective date of dividends of surplus Friday, May 24, 2024

2. Matters concerning appropriation of surplus

  1. Surplus item to be increased and the amount thereof

General reserve

¥3,000,000,000

(2) Surplus item to be decreased and the amount thereof

Retained earnings brought forward

¥3,000,000,000

- 3 -

Proposal 2: Election of 9 Directors

No.

1

2

The terms of office of all 9 Directors will expire at the conclusion of this General Meeting of Shareholders. Accordingly, the election of 9 Directors is proposed.

The candidates for Directors are as follows:

Name

Past experience, positions, responsibilities

Number of

Special

shares of the

interests in the

(Date of birth)

and significant concurrent positions

Company held

Company

April 1999

Joined the Company

February 2007

Head of Corporate Strategy Planning

Kazuhide Nakatomi

May 2007

Director & Executive Officer

(June 30, 1972)

May 2009

Managing Director & Executive Officer

245,742

None

May 2011

Senior Managing Director & Executive Officer

[Reappointment]

May 2014

Vice President & Executive Officer

May 2015

President & COO

May 2019

President & CEO (to present)

[Reason for nomination as candidate]

Mr. Kazuhide Nakatomi has extensive operational experience in the corporate strategy planning division, and took office as Director of the Company in 2007. He also has built track records as a corporate manager since he became Representative Director in 2015. We believe he is suitable for continuing to serve as a Director of the Company, and nominate him as a candidate for Director.

April 1977

Joined the Company

May 1999

Director

Kosuke Sugiyama

February 2010

Director & Executive Officer

(April 28, 1952)

July 2012

Managing Director & Executive Officer

13,000

None

May 2014

Senior Managing Director & Executive Officer

[Reappointment]

[In charge of Human Resources, Research and

Development, and Corporate Strategy Planning] (to

present)

[Reason for nomination as candidate]

Mr. Kosuke Sugiyama has extensive operational experience in the human resources division, and has been managing and supervising management in general, including human resources, since he took office as Director of the Company in 1999. We believe he is suitable for continuing to serve as a Director of the Company, and nominate him as a candidate for Director.

- 4 -

[Reappointment]

No.

3

Name

Past experience, positions, responsibilities

(Date of birth)

and significant concurrent positions

April 1987

Joined the Company

April 2009

Executive Officer

May 2013

Director & Executive Officer

Kyu Saito

May 2023

Managing Director & Executive Officer

[Head of Global Business Strategy, Chairman of

(June 10, 1963)

Hisamitsu America, Inc., President of Hisamitsu

[Reappointment]

Pharmaceutical Technology Consulting (Beijing) Co.,

Ltd., President of Hisamitsu Pharmaceutical (China)

Co., Ltd., President of Hisamitsu U.S., Inc., and

Director of P.T. Hisamitsu Pharma Indonesia] (to

present)

Number of

Special

shares of the

interests in the

Company held

Company

7,100 None

4

[Reason for nomination as candidate]

Mr. Kyu Saito has extensive operational experience in the sales and corporate strategy planning divisions, and has been managing and supervising the overseas sales division since he took office as Director of the Company in 2013. We believe he is suitable for continuing to serve as a Director of the Company, and nominate him as a candidate for Director.

April 1988

Joined the Company

Nobuo Tsutsumi

March 2010

Executive Officer

May 2014

Director & Executive Officer

(March 11, 1964)

[Management of Legal Affairs, Production, Quality

5,200

None

Assurance & Pharmacovigilance, Compliance, and Director of Yutoku Pharmaceutical Ind. Co., Ltd. (part- time)] (to present)

[Reason for nomination as candidate]

Mr. Nobuo Tsutsumi has extensive operational experience in the legal division, and has been managing and supervising legal affairs and compliance based on his high expertise since he took office as Director of the Company in 2014. We believe he is suitable for continuing to serve as a Director of the Company, and nominate him as a candidate for Director.

March 1991

Joined the Company

Shinichi Murayama

March 2012

Executive Officer

May 2014

Director & Executive Officer

(October 16, 1967)

6,000

None

[Management of Internal Audit, Japan Subsidiaries,

[Reappointment]

Director of Yutoku Pharmaceutical Ind. Co., Ltd. (part-

time), and Outside Corporate Auditor of SANOFI-

5

HISAMITSU K.K. (part-time)] (to present)

[Reason for nomination as candidate]

Mr. Shinichi Murayama has extensive operational experience in the sales and corporate strategy planning divisions, and has been managing and supervising management in general, including as Executive Secretary of Chairman's Office, since he took office as Director of the Company in 2014. We believe he is suitable for continuing to serve as a Director of the Company, and nominate him as a candidate for Director.

- 5 -

[Reappointment] [Outside Director]
7 [Independent Officer]

No.

6

Name

Past experience, positions, responsibilities

(Date of birth)

and significant concurrent positions

April 1994

Joined the Company

Koji Takiyama

May 2017

Executive Officer

May 2021

Senior Executive Officer

(October 31, 1971)

May 2022

Director & Executive Officer

[Reappointment]

[Executive Secretary of President's Office, and

Management of Digital Transformation (DX), and

Sustainability Promotion] (to present)

Number of

Special

shares of the

interests in the

Company held

Company

3,035

None

[Reason for nomination as candidate]

Mr. Koji Takiyama has extensive operational experience in the sales division and in the management of Hisamitsu Pharmaceutical Group companies, and has been managing and supervising management in general, including as Executive Secretary of President's Office, since he took office as Director of the Company in 2022. We believe he is suitable for

continuing to serve as a Director of the Company, and nominate him as a candidate for Director.

April 1988

Professor of Faculty of Science and Technology, Keio

University, Professor of Graduate School of Science

and Technology, Keio University

October 1993

Dean of Faculty of Science and Technology, Keio

University

Dean of Graduate School of Science and Technology,

Keio University

May 2001

President of Keio University (Chair of the Board of

Trustees of Keio University and the university

Yuichiro Anzai

president of Keio University)

May 2009

Advisor for Academic Affairs to Keio University (to

(August 29, 1946)

present)

April 2010

Director of the Nakatomi Foundation (to present)

300

None

June 2011

Chairman of Japanese Association of University

Physical Education and Sports

October 2011

President of Japan Society for the Promotion of Science

(JSPS)

April 2012

Professor Emeritus of Keio University (to present)

February 2018

President of Kojunsha Club (to present)

April 2018

Senior Advisor to JSPS (to present)

Director of Research Center for Science Systems, JSPS

May 2020

Outside Director of the Company (to present)

July 2020

Executive Director of The Tokyo Foundation for Policy

Research

December 2020

Executive Director and Chief Executive Officer of The

Tokyo Foundation for Policy Research (to present)

[Reason for nomination as candidate and summary of expected roles]

Mr. Yuichiro Anzai, who has long served as a manager of a university, has a wide range of knowledge and experience, and we expect him to provide precise advice on the Company's management. Furthermore, there is no problem with his independence in relationship with the Company. We believe he is suitable for continuing to serve as an Outside Director of the Company, and nominate him as a candidate for Outside Director.

- 6 -

Name

Past experience, positions, responsibilities

Number of

Special

No.

shares of the

interests in the

(Date of birth)

and significant concurrent positions

Company held

Company

April 2001

Joined Matsuo Construction Co., Ltd.

June 2005

Managing Director of Matsuo Construction Co., Ltd.

Tetsugo Matsuo

June 2006

President of Matsuo Construction Co., Ltd. (to present)

June 2012

Outside Director of FM Saga Co., Ltd. (to present)

(January 1, 1972)

June 2013

Outside Director of Saga Ube Concrete Kogyo Co.,

1,900

None

[Reappointment]

Ltd. (to present)

May 2016

Chairman of Saga General Construction Association (to

[Outside Director]

present)

8

[Independent Officer]

May 2020

Outside Director of the Company (to present)

June 2023

Outside Director of New Otani Kyushu Co., Ltd. (to

present)

[Reason for nomination as candidate and summary of expected roles]

Mr. Tetsugo Matsuo has extensive experience and insight into overall management acquired as a representative director of a

construction company, and we expect him to provide precise advice on the Company's management. Furthermore, there is no

problem with his independence in relationship with the Company. We believe he is suitable for continuing to serve as an

Outside Director of the Company, and nominate him as a candidate for Outside Director.

April 2004

Joined KPMG AZSA LLC

May 2006

Registered as a certified public accountant

Tamako Watanabe

April 2008

Joined ASG Tax Corporation

August 2010

Registered as a certified tax accountant

(January 26, 1982)

July 2011

Joined Odaki Accounting, Tax and Consulting

0

None

[Reappointment]

General Manager of Tateyama Office

September 2011

Registered as a licensed social insurance consultant

[Outside Director]

July 2019

Established Itsuki Accounting Firm

9

[Independent Officer]

Representative (to present)

May 2023

Outside Director of the Company (to present)

December 2023

Outside Auditor of SHOEI CO., LTD. (to present)

[Reason for nomination as candidate and summary of expected roles]

Ms. Tamako Watanabe has a wide range of knowledge and experience acquired as a certified public accountant, a certified tax accountant and a licensed social insurance consultant, and we expect her to provide precise advice on the Company's management. Furthermore, there is no problem with her independence in relationship with the Company. We believe she is suitable for continuing to serve as an Outside Director of the Company, and nominate her as a candidate for Outside Director.

(Notes)

1.

Messrs. Yuichiro Anzai and Tetsugo Matsuo and Ms. Tamako Watanabe are candidates for Outside Directors.

2.

Messrs. Yuichiro Anzai and Tetsugo Matsuo and Ms. Tamako Watanabe, candidates for Outside Directors, satisfy the

requirements of independent officers stipulated by Tokyo Stock Exchange, Inc., Nagoya Stock Exchange, Inc. and

Fukuoka Stock Exchange, respectively, and the Company has notified these stock exchanges of them as independent

officers.

3.

At the conclusion of this General Meeting of Shareholders, Messrs. Yuichiro Anzai and Tetsugo Matsuo will have served

for four years, and Ms. Tamako Watanabe will have served for one year as Outside Directors of the Company.

4.

The Company has entered into agreements with Messrs. Yuichiro Anzai and Tetsugo Matsuo and Ms. Tamako Watanabe

in accordance with Article 427, Paragraph 1 of the Companies Act, to limit the liability for damages set forth in Article

423, Paragraph 1 of the same act to the amount stipulated by laws and regulations. If this proposal is approved, the

Company plans to continue the said agreements with them.

5.

The Company has concluded a directors and officers liability insurance contract with an insurance company, and all

candidates for this election proposal will be insured under the contract. The insurance contract covers damages that may

arise from the insured directors and officers assuming liability for the execution of their duties or receiving claims related

to the pursuit of such liability.

- 7 -

No.

1

2

Proposal 3: Election of 3 Corporate Auditors

The term of office of Messrs. Nobuyuki Nakatomi, Munehiko Hirano and Keinosuke Ono, 3 of the total 4 Corporate Auditors, will expire at the conclusion of this General Meeting of Shareholders. Accordingly, the election of three Corporate Auditors is proposed.

The Board of Corporate Auditors has given its consent to this proposal. The candidates for Corporate Auditor are as follows:

Name

Number of

Special

Past experience, positions and significant concurrent positions

shares of the

interests in the

(Date of birth)

Company held

Company

Nobuyuki Nakatomi

September 1988

Joined Cable Television Kurume Co., Ltd.

(September 7, 1940)

April 1990

President of Cable Television Kurume Co., Ltd.

250,200

None

May 1999

Director of the Company

[Reappointment]

May 2008

Corporate Auditor of the Company (to present)

[Reason for nomination as candidate]

Mr. Nobuyuki Nakatomi has long been engaged in management of Hisamitsu Pharmaceutical Group companies and has extensive experience of managing and supervising management of the Company in general as Director. Based on the experience, he has been auditing the Company since he took office as Corporate Auditor of the Company in 2008. We believe he is suitable for continuing to serve as a Corporate Auditor of the Company and nominate him as a candidate for Corporate Auditor.

April 1974

Joined the Company

April 1997

Head of Pharmaceutical Formulation

Munehiko Hirano

Laboratories, Research and Development

(September 20, 1947)

Headquarters of the Company

2,300

None

February 2005

General Manager in charge of Pharmaceutical

[Reappointment]

Formulation Technology, Research and

Development Headquarters of the Company

May 2006

Corporate Auditor of the Company (to present)

[Reason for nomination as candidate]

Mr. Munehiko Hirano has extensive operational experience in the research and development division. Based on the experience, he has been auditing the Company since he took office as Corporate Auditor of the Company in 2006. We believe he is suitable for continuing to serve as a Corporate Auditor of the Company and nominate him as a candidate for Corporate Auditor.

- 8 -

Name

Number of

Special

No.

Past experience, positions and significant concurrent positions

shares of the

interests in the

(Date of birth)

Company held

Company

March 1979

Joined the Mitsui Bank, Limited (currently

Sumitomo Mitsui Banking Corporation)

April 2006

Executive Officer and General Manager of

Consumer Loan Dept. of Sumitomo Mitsui

Banking Corporation

Ryusuke Itakura

April 2007

Executive Officer and Deputy Head of

Consumer Banking Unit (in charge of West

(November 17, 1955)

Japan) of Sumitomo Mitsui Banking

[New Appointment]

Corporation

0

None

June 2009

Representative Director and President of SMBC

[Outside Corporate Auditor]

3

[Independent Officer]

Guarantee Co., Ltd.

June 2013

Representative Director and President of

Muromachi Building Service Co., Ltd.

May 2019

Director of Tanioka Gakuen Educational

Foundation (to present)

June 2019

Outside Audit & Supervisory Board Member of

Futaba Industrial Co., Ltd.

[Reason for nomination as candidate]

Mr. Ryusuke Itakura has knowledge of finance he acquired over many years in the financial industry and experience as a corporate manager. We nominate him as a candidate for Corporate Auditor in order for him to provide precise advice on the Company's management and since there is no problem with his independence in relationship with the Company. We believe he is suitable for serving as an Outside Corporate Auditor of the Company.

(Notes)

1.

Mr. Ryusuke Itakura is a candidate for Outside Corporate Auditor.

2.

Mr. Ryusuke Itakura, a candidate for Outside Corporate Auditor, satisfies the requirements of independent officers

stipulated by Tokyo Stock Exchange, Inc., Nagoya Stock Exchange, Inc. and Fukuoka Stock Exchange, respectively.

The Company has notified the stock exchanges that if this proposal to appoint Mr. Ryusuke Itakura as a Corporate

Auditor is approved, he will be an independent officer.

3.

If this proposal is approved, the Company plans to enter into an agreement with Mr. Ryusuke Itakura in accordance with

Article 427, Paragraph 1 of the Companies Act, to limit the liability for damages set forth in Article 423, Paragraph 1 of

the same act to the amount stipulated by laws and regulations.

4.

The Company has concluded a directors and officers liability insurance contract with an insurance company, and all

candidates for this election proposal will be insured under the contract. The insurance contract covers damages that may

arise from the insured directors and officers assuming liability for the execution of their duties or receiving claims related

to the pursuit of such liability.

- 9 -

(Reference)

(1) Skill matrix of Directors and Corporate Auditors (planned) after this Annual General Meeting of Shareholders

The Company elects multiple Outside Directors within the limits of the number specified in the Companies Act and the Company's Articles of Incorporation, so that its Board of Directors is both diverse and effective, with a good balance of members who possess the knowledge, experience, and skills needed to effectively perform their roles and responsibilities. If Proposal 2 and Proposal 3 are approved as originally proposed, the composition of the Company's Directors and Corporate Auditors, and experience and expertise of each Director and Corporate Auditor are as follows:

IT / Digital

HR

Legal affairs /

Name

Corporate

Sales /

Global /

Production /

transformation management / Sustainability Compliance /

Finance /

management

Marketing

Business

R&D

(DX)

development

/ ESG

Risk

Accounting

management

Directors

Corporate Auditors

Kazuhide Nakatomi

Kosuke Sugiyama

Kyu Saito

Nobuo Tsutsumi

Shinichi Murayama

Koji Takiyama

Yuichiro Anzai

Tetsugo Matsuo

Tamako Watanabe

Nobuyuki Nakatomi

Munehiko Hirano

Kentaro Watanabe

Ryusuke Itakura

- 10 -

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Hisamitsu Pharmaceutical Co. Ltd. published this content on 25 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 April 2024 08:03:05 UTC.